NCT06594822CompletedPhase 3
Effectiveness of Probiotics in Patients of Mild to Moderate Rheumatoid Arthritis
Effectiveness of Probiotics and Standard Therapy Versus Standard Therapy Alone in Patients of Mild to Moderate Rheumatoid Arthritis
Source: ClinicalTrials.gov · Last updated 19 Sept 2024
Brief summary (registry, in English)
To assess the effectiveness of probiotics when given in combination with standard therapy in patients of mild to moderate rheumatoid arthritis
- Status (registry)
- Completed
- Phase (registry)
- Phase 3
- Study type
- Interventional
- Enrollment
- 88 (actual)
- First submitted
- 18 Aug 2024
- Start date
- 24 Aug 2023
- Primary completion date
- 23 Jan 2024
- Lead sponsor
- King Edward Medical University
- Diseases
- Rheumatoid arthritis
- NCT number
- NCT06594822
What you commit to
- Study type: Interventional · Phase 3
- Participants enrolled: 88
- From 24 Aug 2023 to the primary completion date, 23 Jan 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- 4- Patients with a history of gastrectomy, renal failure and liver cirrhosis. 5- Patients with recent or current use of antibiotics. 6- Pregnant patients and lactating mothers.
Other
- \-
Who the study is looking for
- 4- Patients having mild to moderate disease activity (DAS-28 score between 2.6 to \<5.1).
Age in the registry: 18 years to 70 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Tazeen Nazar Coordinator of this site? Confirm its status | Lahore | Pakistan | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.